๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

5FU infusion with mitomycin-C versus 5FU infusion with methyl-CCNU in the treatment of advanced colon cancer. A southwest oncology group study

โœ Scribed by Thomas Buroker; P. N. Kim; Carl Groppe; Joseph McCracken; Robert O'Bryan; Frank Panettiere; Charles Coltman; Richard Bottomley; Henry Wilson; John Bonnet; Tate Thigpen; V. K. Vaitkevicius; Barth Hoogstraten; Lance Heilbrun

Publisher
John Wiley and Sons
Year
1978
Tongue
English
Weight
493 KB
Volume
42
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II study of 5-fluorouracil and fol
Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer: A Southwest Oncology Group study
โœ Giuseppe Colucci ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 71 KB ๐Ÿ‘ 2 views

n the article published in Cancer entitled "Phase I1 study of 5-fluoro-I uracil and folinic acid in the treatment of patients with advanced gastric cancer. A Southwest Oncology Group Study,"' the authors erroneously quoted the results of our study and we request a correction. In the results of our

Evaluation of low dose continuous infusi
Evaluation of low dose continuous infusion 5-fluorouracil in patients with advanced and recurrent renal cell carcinoma. A Southwest Oncology Group study
โœ Julie A. Kish; Michael Wolf; E. David Crawford; Joseph T. Leimert; Anton Buesche ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 289 KB ๐Ÿ‘ 2 views

Background. The response rate of metastatic renal cell cancer to cytotoxic therapy over the last 10 years has been 5.6%. Low dose continuous 5-fluorouracil(5-FU) has demonstrated efficacy in other cytotoxic refractory tumors, such as pancreas, colorectal, and recurrent breast. The Southwest Oncology